benzoxazoles has been researched along with Amphetamine-Related Disorders in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hedou, G; Heidbreder, C; Hutcheson, DM; Quarta, D; Valerio, E | 1 |
1 other study(ies) available for benzoxazoles and Amphetamine-Related Disorders
| Article | Year |
|---|---|
The orexin-1 receptor antagonist SB-334867 reduces amphetamine-evoked dopamine outflow in the shell of the nucleus accumbens and decreases the expression of amphetamine sensitization.
Topics: Amphetamine; Amphetamine-Related Disorders; Animals; Benzoxazoles; Dopamine; Dopamine Uptake Inhibitors; Extracellular Fluid; Hypothalamus; Intracellular Signaling Peptides and Proteins; Male; Microdialysis; Naphthyridines; Neural Pathways; Neuropeptides; Nucleus Accumbens; Orexin Receptors; Orexins; Rats; Rats, Sprague-Dawley; Receptors, G-Protein-Coupled; Receptors, Neuropeptide; Reward; Synaptic Transmission; Urea | 2010 |